Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Β1316dglucan

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 2 (1)
Phase 4 (1)

Trial Status

Completed3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07056257Not ApplicableCompleted

Adjunct Use of Diode Laser Therapy and Omega 3 Gel in Local Drug Delivery Approach on The Treatment of Localized Aggressive Periodontitis

NCT04722380Phase 2UnknownPrimary

Nigella Sativa Oil Extract and Xenograft Bone Graft in Treatment of Infra-bony Defects

NCT03625414CompletedPrimary

Tissue Alterations in Aggressive and Chronic Periodontitis

NCT02402296Phase 4CompletedPrimary

Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis

Showing all 4 trials

Research Network

Common Treatments

  • Β1316dglucan1
  • Periodontal Regenerative Surgery1
  • Scalingroot Planning Srp1
  • Scalingroot Planning Srp Laser Therapy1
  • Scalingroot Planning Srp Laser Therapy Omega 3 Gel1

Active Sponsors

  • Tanta University2
  • Tokat Gaziosmanpasa University1
  • Al-Azhar University1

Top Investigators

Related Conditions

  • Diode Laser Therapy1
  • Omega 31
  • Chronic Periodontitis1

Activity Timeline